第 1 章 参考文献
1. Thiery, J.P., Sleeman, J.P., 2006. Complex networks orchestrate epithelial- mesenchymal transitions. Nat. Rev. Mol. Cell Biol.
2. Kalluri, R., Weinberg, R.A., 2009. The basics of epithelial-mesenchymal transition. J. Clin. Invest.
3. Jayachandran, A., Königshoff, M., Yu, H., Rupniewska, E., Hecker, M., Klepetko, W., Seeger, W., Eickelberg, O., 2009. SNAI transcription factors mediate epithelial- mesenchymal transition in lung fibrosis. Thorax 64, 1053–1061.
4. Xu, J., Lamouille, S., Derynck, R., 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19, 156–172.
5. Kasai, H., Allen, J.T., Mason, R.M., Kamimura, T., Zhang, Z., 2005. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 6, 56.
6. Kopan, R., Ilagan, M.X.G., 2009. The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism. Cell.
7. Lai, E.C., 2004. Notch signaling: Control of cell communication and cell fate. Development.
8. Matsuno, Y., Coelho, A.L., Jarai, G., Westwick, J., Hogaboam, C.M., 2012. Notch signaling mediates TGF-beta1-induced epithelial-mesenchymal transition through the induction of Snai1. Int J Biochem Cell Biol 44, 776–789.
9. Boudreau, H.E., Casterline, B.W., Burke, D.J., Leto, T.L., 2014. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells. Br J Cancer 110, 2569–2582.
10. Wang, D., Yan, Z., Bu, L., An, C., Deng, B., Zhang, J., Rao, J., Cheng, L., Zhang, J., Zhang, B., Xie, J., 2019. Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress. Toxicol Appl Pharmacol 382, 114703.
11. Reuter, S., Gupta, S.C., Chaturvedi, M.M., Aggarwal, B.B., 2010. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med.
12. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., Yamamoto, M., 2004. Oxidative stress sensor Keap1 functions as an adaptor for Cul3‐based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24, 7130–7139.
13. Itoh, K., Tong, K.I., Yamamoto, M., 2004. Molecular mechanism activating Nrf2‐ Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36, 1208–1213.
14. Hamanaka, R.B., Glasauer, A., Hoover, P., Yang, S., Blatt, H., Mullen, A.R., Getsios, S., Gottardi, C.J., DeBerardinis, R.J., Lavker, R.M., Chandel, N.S., 2013. Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci Signal 6, ra8.
15. Jain, M., Rivera, S., Monclus, E.A., Synenki, L., Zirk, A., Eisenbart, J., Feghali- Bostwick, C., Mutlu, G.M., Budinger, G.R., Chandel, N.S., 2013. Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling. J Biol Chem 288, 770–777.
16. Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T.R., Horowitz, J.C., Pennathur, S., Martinez, F.J., Thannickal, V.J., 2009. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 15, 1077–1081.
17. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P.J., Ariyan, S., Dikalov, S., Sorescu, D., 2005. NAD(P)H oxidase 4 mediates transforming growth factor-β1- induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97, 900–907.
18. Carmona-Cuenca, I., Roncero, C., Sancho, P., Caja, L., Fausto, N., Fernández, M., Fabregat, I., 2008. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J. Hepatol. 49, 965–976.
19. Wakabayashi, N., Shin, S., Slocum, S.L., Agoston, E.S., Wakabayashi, J., Kwak, M.K., Misra, V., Biswal, S., Yamamoto, M., Kensler, T.W., 2010. Regulation of Notch1 signaling by Nrf2: Implications for tissue regeneration. Sci. Signal. 3.
20. Paul, M.K., Bisht, B., Darmawan, D.O., Chiou, R., Ha, V.L., Wallace, W.D., Chon, A.T., Hegab, A.E., Grogan, T., Elashoff, D.A., Alva-Ornelas, J.A., Gomperts, B.N., 2014. Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling. Cell Stem Cell 15, 199–214.
21. Amsen, D., Antov, A., Flavell R.A., 2009. The different faces of Notch in T-helper- cell differentiation. Nat Rev Immunol 9, 116–124.
第 2 章
1. Matsuno, Y., Coelho, A.L., Jarai, G., Westwick, J., Hogaboam, C.M., 2012. Notch signaling mediates TGF-beta1-induced epithelial-mesenchymal transition through the induction of Snai1. Int J Biochem Cell Biol 44, 776–789.
2. Carnesecchi, S., Deffert, C., Donati, Y., Basset, O., Hinz, B., Preynat-Seauve, O., Guichard, C., Arbiser, J.L., Banfi, B., Pache, J.C., Barazzone-Argiroffo, C., Krause, K.H., 2011. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxidants Redox Signal. 15, 607–619.
3. Liu, R.M., Desai, L.P., 2015. Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis. Redox Biol.
4. Arfmann-Knubel, S., Struck, B., Genrich, G., Helm, O., Sipos, B., Sebens, S., Schafer, H., 2015. The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells. PLoS One 10.
5. Martin, D., Rojo, A.I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., Ruiz De Galarreta, C.M., Cuadrado, A., 2004. Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol. J. Biol. Chem. 279, 8919–8929.
6. Ning, W., Song, R., Li, C., Park, E., Mohsenin, A., Choi, A.M., Choi, M.E., 2002. TGF-beta1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 283, L1094-102.
7. Tormos, A.M., Taléns-Visconti, R., Nebreda, A.R., Sastre, J., 2013. P38 MAPK: A dual role in hepatocyte proliferation through reactive oxygen species. Free Radic. Res.
8. Wakabayashi, N., Shin, S., Slocum, S.L., Agoston, E.S., Wakabayashi, J., Kwak, M.K., Misra, V., Biswal, S., Yamamoto, M., Kensler, T.W., 2010. Regulation of Notch1 signaling by Nrf2: Implications for tissue regeneration. Sci. Signal. 3.
9. Zhao, Q., Mao, A., Yan, J., Sun, C., Di, C., Zhou, X., Li, H., Guo, R., Zhang, H., 2016. Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells. Int. J. Oncol. 48, 765– 773.
10. Paul, M.K., Bisht, B., Darmawan, D.O., Chiou, R., Ha, V.L., Wallace, W.D., Chon, A.T., Hegab, A.E., Grogan, T., Elashoff, D.A., Alva-Ornelas, J.A., Gomperts, B.N., 2014. Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling. Cell Stem Cell 15, 199– 214.
11. Blokzijl, A., Dahlqvist, C., Reissmann, E., Falk, A., Moliner, A., Lendahl, U., Ibáñez, C.F., 2003. Cross-talk between the Notch and TGF-β signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J. Cell Biol. 163, 723–728.
12. Frohlich, D.A., McCabe, M.T., Arnold, R.S., Day, M.L., 2008. The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene 27, 4353–4362.
13. Iskander, K., Paquet, M., Brayton, C., Jaiswal, A.K., 2004. Deficiency of NRH:Quinone oxidoreductase 2 increases susceptibility to 7,12- dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res. 64, 5925–5928.
14. Long, D.J., Waikel, R.L., Wang, X.J., Roop, D.R., Jaiswal, A.K., 2001. NAD(P)H: Quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12- dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J. Natl. Cancer Inst. 93, 1166–1170.
15. Satoh, H., Moriguchi, T., Takai, J., Ebina, M., Yamamoto, M., 2013. Nrf2 prevents initiation but accelerates progression through the kras signaling pathway during lung carcinogenesis. Cancer Res. 73, 4158–4168.
16. Wang, H., Liu, X., Long, M., Huang, Y., Zhang, L., Zhang, R., Zheng, Y., Liao, X., Wang, Y., Liao, Q., Li, W., Tang, Z., Tong, Q., Wang, X., Fang, F., De La Vega, M.R., Ouyang, Q., Zhang, D.D., Yu, S., Zheng, H., 2016. NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis. Sci. Transl. Med.
17. Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., Shibata, T., Yamamoto, M., Hirohashi, S., 2008. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68, 1303–1309.
18. Wang, Q., Ma, J., Lu, Y., Zhang, S., Huang, J., Chen, J., Bei, J.X., Yang, K., Wu, G., Huang, K., Chen, J., Xu, S., 2017. CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells. Oncogene 36, 5321–5330.
19. Collisson, E.A., Campbell, J.D., Brooks, A.N., Berger, A.H., Lee, W., Chmielecki, J., Beer, D.G., Cope, L., Creighton, C.J., Danilova, L., Ding, L., Getz, G., Hammerman, P.S., Hayes, D.N., Hernandez, B., Herman, J.G., Heymach, J. V., Jurisica, I., Kucherlapati, R., Kwiatkowski, D., Ladanyi, M., Robertson, G., Schultz, N., Shen, R., Sinha, R., Sougnez, C., Tsao, M.S., Travis, W.D., Weinstein, J.N., Wigle, D.A., Wilkerson, M.D., Chu, A., Cherniack, A.D., Hadjipanayis, A., Rosenberg, M., Weisenberger, D.J., Laird, P.W., Radenbaugh, A., Ma, S., Stuart, J.M., Byers, L.A., Baylin, S.B., Govindan, R., Meyerson, M., Gabriel, S.B., Cibulskis, K., Kim, J., Stewart, C., Lichtenstein, L., Lander, E.S., Lawrence, M.S., Getz, E., Fulton, R., Fulton, L.L., McLellan, M.D., Wilson, R.K., Ye, K., Fronick, C.C., Maher, C.A., Miller, C.A., Wendl, M.C., Cabanski, C., Mardis, E., Wheeler, D., Balasundaram, M., Butterfield, Y.S.N., Carlsen, R., Chuah, E., Dhalla, N., Guin, R., Hirst, C., Lee, D., Li, H.I., Mayo, M., Moore, R.A., Mungall, A.J., Schein, J.E., Sipahimalani, P., Tam, A., Varhol, R., Robertson, A.G., Wye, N., Thiessen, N., Holt, R.A., Jones, S.J.M., Marra, M.A., Imielinski, M., Onofrio, R.C., Hodis, E., Zack, T., Helman, E., Pedamallu, C.S., Mesirov, J., Saksena, G., Schumacher, S.E., Carter, S.L., Garraway, L., Beroukhim, R., Lee, S., Mahadeshwar, H.S., Pantazi, A., Protopopov, A., Ren, X., Seth, S., Song, X., Tang, J., Yang, Lixing, Zhang, J., Chen, P.C., Parfenov, M., Xu, A.W., Santoso, N., Chin, L., Park, P.J., Hoadley, K.A., Auman, J.T., Meng, S., Shi, Y., Buda, E., Waring, S., Veluvolu, U., Tan, D., Mieczkowski, P.A., Jones, C.D., Simons, J. V., Soloway, M.G., Bodenheimer, T., Jefferys, S.R., Roach, J., Hoyle, A.P., Wu, J., Balu, S., Singh, D., Prins, J.F., Marron, J.S., Parker, J.S., Perou, C.M., Liu, J., Maglinte, D.T., Lai, P.H., Bootwalla, M.S., Van Den Berg, D.J., Triche, T., Cho, J., DiCara, D., Heiman, D., Lin, P., Mallard, W., Voet, D., Zhang, H., Zou, L., Noble, M.S., Gehlenborg, N., Thorvaldsdottir, H., Nazaire, M.D., Robinson, J., Aksoy, B.A., Ciriello, G., Taylor, B.S., Dresdner, G., Gao, J., Gross, B., Seshan, V.E., Reva, B., Sumer, S.O., Weinhold, N., Sander, C., Ng, S., Zhu, J., Benz, C.C., Yau, C., Haussler, D., Spellman, P.T., Kimes, P.K., Broom, B.M., Wang, J., Lu, Y., Ng, P.K.S., Diao, L., Liu, W., Amos, C.I., Akbani, R., Mills, G.B., Curley, E., Paulauskis, J., Lau, K., Morris, S., Shelton, T., Mallery, D., Gardner, J., Penny, R., Saller, C., Tarvin, K., Richards, W.G., Cerfolio, R., Bryant, A., Raymond, D.P., Pennell, N.A., Farver, C., Czerwinski, C., Huelsenbeck-Dill, L., Iacocca, M., Petrelli, N., Rabeno, B., Brown, J., Bauer, T., Dolzhanskiy, C.O., Potapova, O., Rotin, D., Voronina, O., Nemirovich-Danchenko, E., Fedosenko, K. V., Gal, A., Behera, M., Ramalingam, S.S., Sica, G., Flieder, D., Boyd, J., Weaver, J.E., Kohl, B., Thinh, D.H.Q., Sandusky, G., Juhl, H., Duhig, E., Illei, P., Gabrielson, E., Shin, J., Lee, B., Rogers, K., Trusty, D., Brock, M. V., Williamson, C., Burks, E., Rieger-Christ, K., Holway, A., Sullivan, T., Asiedu, M.K., Kosari, F., Rekhtman, N., Zakowski, M., Rusch, V.W., Zippile, P., Suh, J., Pass, H., Goparaju, C., Owusu-Sarpong, Y., Bartlett, J.M.S., Kodeeswaran, S., Parfitt, J., Sekhon, H., Albert, M., Eckman, J., Myers, J.B., Morrison, C., Gaudioso, C., Borgia, J.A., Bonomi, P., Pool, M., Liptay, M.J., Moiseenko, F., Zaytseva, I., Dienemann, H., Meister, M., Schnabel, P.A., Muley, T.R., Peifer, M., Gomez-Fernandez, C., Herbert, L., Egea, S., Huang, M., Thorne, L.B., Boice, L., Salazar, A.H., Funkhouser, W.K., Rathmell, W.K., Dhir, R., Yousem, S.A., Dacic, S., Schneider, F., Siegfried, J.M., Hajek, R., Watson, M.A., McDonald, S., Meyers, B., Clarke, B., Yang, I.A., Fong, K.M., Hunter, L., Windsor, M., Bowman, R. V., Peters, S., Letovanec, I., Khan, K.Z., Jensen, M.A., Snyder, E.E., Srinivasan, D., Kahn, A.B., Baboud, J., Pot, D.A., Shaw, K.R.M., Sheth, M., Davidsen, T., Demchok, J.A., Yang, Liming, Wang, Z., Tarnuzzer, R., Zenklusen, J.C., Ozenberger, B.A., Sofia, H.J., Cheney, R., 2014. Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network. Nature 511, 543–550.
20. Qian, Z., Zhou, T., Gurguis, C.I., Xu, X., Wen, Q., Lv, J., Fang, F., Hecker, L., Cress, A.E., Natarajan, V., Jacobson, J.R., Zhang, D.D., Garcia, J.G.N., Wang, T., 2015. Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival. Sci. Rep. 5.
21. Shin, D.H., Park, H.M., Jung, K.A., Choi, H.G., Kim, J.A., Kim, D.D., Kim, S.G., Kang, K.W., Ku, S.K., Kensler, T.W., Kwak, M.K., 2010. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radic. Biol. Med. 48, 1051–1063.
22. Zhou, W., Mo, X., Cui, W., Zhang, Z., Li, D., Li, L., Xu, L., Yao, H., Gao, J., 2016. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis. Sci. Rep. 6, 1–10.
23. Wu, Y.S., Chung, I., Wong, W.F., Masamune, A., Sim, M.S., Looi, C.Y., 2017. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial- mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Biochim. Biophys. Acta - Gen. Subj. 1861, 296–306.
24. Chien, M.H., Lee, W.J., Hsieh, F.K., Li, C.F., Cheng, T.Y., Wang, M.Y., Chen, J.S., Chow, J.M., Jan, Y.H., Hsiao, M., Hua, K.T., Kuo, M.L., 2015. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein. Clin Cancer Res 21, 4719–4732.
25. Park, S.-H., Kim, J.H., Ko, E., Kim, J.-Y., Park, M.-J., Kim, M.J., Seo, H., Li, S., Lee, J.-Y., 2018. Resistance to gefitinib and cross‐resistance to irreversible EGFR‐TKIs mediated by disruption of the Keap1‐Nrf2 pathway in human lung cancer cells. FASEB J. 32, 5862–5873.
26. Shen, H., Yang, Y., Xia, S., Rao, B., Zhang, J., Wang, J., 2014. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment. Dis. Esophagus 27, 685–692.
27. Pan, S.T., Qin, Y., Zhou, Z.W., He, Z.X., Zhang, X., Yang, T., Yang, Y.X., Wang, D., Zhou, S.F., Qiu, J.X., 2015. Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells. Drug Des. Devel. Ther. 9, 5511–5551.
28. Han, W., Zhang, Y., Niu, C., Guo, J., Li, J., Wei, X., Jia, M., Zhi, X., Yao, L., Meng, D., 2019. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition. Cancer Lett. 445, 45–56.
29. Sato, M., Matsumoto, M., Saiki, Y., Alam, M., Nishizawa, H., Rokugo, M., Brydun, A., Yamada, S., Kaneko, M.K., Funayama, R., Ito, M., Kato, Y., Nakayama, K., Unno, M., Igarashi, K., 2020. BACH1 promotes pancreatic cancer metastasis by repressing epithelial genes and enhancing epithelial-mesenchymal transition. Cancer Res. 80, 1279–1292.
30. Lignitto, L., LeBoeuf, S.E., Homer, H., Jiang, S., Askenazi, M., Karakousi, T.R., Pass, H.I., Bhutkar, A.J., Tsirigos, A., Ueberheide, B., Sayin, V.I., Papagiannakopoulos, T., Pagano, M., 2019. Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1. Cell 178, 316-329.e18.
31. Wiel, C., Le Gal, K., Ibrahim, M.X., Sayin, V.I., Bergo, M.O., Jahangir, C.A., Kashif, M., Yao, H., Ziegler, D. V, Xu, X., Ghosh, T., Mondal, T., Kanduri, C., Lindahl, P., 2019. BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis Article BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis. Cell 178, 330-345.e22.
32. Gallahan, D., Callahan, R., 1987. Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. J. Virol. 61, 66–74.
33. Uyttendaele, H., Marazzi, G., Wu, G., Yan, Q., Sassoon, D., Kitajewski, J., 1996. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122.
34. Uyttendaele, H., Ho, J., Rossant, J., Kitajewski, J., 2001. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl. Acad. Sci. U. S. A. 98, 5643–5648.
35. Bui, Q.T., Im, J.H., Jeong, S.B., Kim, Y.M., Lim, S.C., Kim, B., Kang, K.W., 2017. Essential role of Notch4/STAT3 signaling in epithelial–mesenchymal transition of tamoxifen-resistant human breast cancer. Cancer Lett. 390, 115–125.
36. Fukusumi, T., Guo, T.W., Sakai, A., Ando, M., Ren, S., Haft, S., Liu, C., Amornphimoltham, P., Silvio Gutkind, J., Califano, J.A., 2018. The NOTCH4–HEY1 pathway induces epithelial–mesenchymal transition in head and neck squamous cell carcinoma. Clin. Cancer Res. 24, 619–633.
37. Lin, X., Sun, B., Zhu, D., Zhao, X., Sun, R., Zhang, Y., Zhang, D., Dong, X., Gu, Q., Li, Y., Liu, F., 2016. Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma. Cancer Sci. 107, 1079–1091.
38. Zhang, J., Kuang, Y., Wang, Y., Xu, Q., Ren, Q., 2017. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway. Apoptosis 22, 877–884.
39. Onder, T.T., Gupta, P.B., Mani, S.A., Yang, J., Lander, E.S., Weinberg, R.A., 2008. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645–3654.
40. Peinado, H., Olmeda, D., Cano, A., 2007. Snail, ZEB and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat. Rev. Cancer.